Which Strategy Is More Effective for the Treatment of Cardiovascular Disease: High-Dose Angiotensin II Type 1 Receptor Antagonist Monotherapy or Combination Therapy?

Author： Miura Shin-ichiro   Saku Keijiro  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.8, Iss.2, 2008-01, pp. : 88-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ACE Inhibitor, Angiotensin II Receptor Antagonist, Monotherapy or Combined Therapy?

By  

Heart Drug, Vol. 4, Iss. 3, 2004-08 ,pp. : 145-150

Karger

Access to resources Recommend Favorite

Antihypertensive Efficacy of the Losartan/Hydrochlorothiazide Combination and its Effect on Plasma B-Type Natriuretic Peptide in Hypertensive Patients Uncontrolled by Angiotensin II Type 1 Receptor Antagonist-Based Therapy: A Multicentre Prospective Observational Study

By Meno Hiroshi  

Clinical Drug Investigation, Vol. 32, Iss. 3, 2012-03 ,pp. : 171-178

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Angiotensin II Type 1 Receptor Blocker/Calcium Channel Blocker Combination Therapy for Hypertension: Focus on a Single-pill Fixed-dose Combination of Valsartan and Amlodipine

By Miura S   Saku K  

The Journal of International Medical Research, Vol. 40, Iss. 1, 2012-01 ,pp. : 1-9

Field House Publishing

Access to resources Recommend Favorite

Comparative effects of tamoxifen and angiotensin II type-1 receptor antagonist therapy on the hemodynamic profile of the ovariectomized female rat

By Pham-Dang My-Lan   Clement Robert   Mercier Isabelle   Calderone Angelino  

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 9, 2003-09 ,pp. : 915-919

NRC Research Press

Access to resources Recommend Favorite

Valsartan: a novel angiotensin Type 1 receptor antagonist

By Thürmann P.A.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. : 337-350

Informa Healthcare

Access to resources Recommend Favorite